ArticleOncotarget2024

The advances in targeting CD47/SIRPα "do not eat me" axis and their ongoing challenges as an anticancer therapy.

Maria Gracia-Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.